• Most Popular
  • Most Shared

UPDATE 1-InterMune 3rd-quarter loss narrows

Thu Nov 1, 2007 4:37pm EDT

Stocks

   

Stocks

(Adds revenue, R&D details, background)

NEW YORK, Nov 1 (Reuters) - InterMune Inc (ITMN.O) on Thursday reported a narrower third-quarter loss than a year ago, when it took a legal settlement charge and had higher research expenses.

The Brisbane, California-based biotechnology company posted a net loss of $23.1 million, or 66 cents per share, compared with a loss of $29 million, or 88 cents per share, a year earlier.

Analysts, on average, expected a loss of 65 cents per share, according to Reuters Estimates.

Revenue fell to $11.4 million from $22.5 million as sales of Actimmune, its immune system boosting drug, dropped 53 percent to $10.6 million.

Actimmune sales have dried up since a clinical trial failed to show a benefit in the lung disease, idiopathic pulmonary fibrosis. The vast majority of the drug's sales had come from off-label use for the lung disease, but most doctors stopped prescribing it for that use once the trial failed.

Third-quarter research and development expenses were down by 27 percent to $23.4 million, reflecting the halting of the late-stage clinical trial of Actimmune for pulmonary fibrosis.

The company is currently testing another experimental drug for the lung disorder.

(Reporting by Bill Berkrot)

((Reuters Messaging: bill.berkrot.reuters.com@reuters.net phone 646 223-6030; editing by Carol Bishopric/Jeffrey Benkoe)) Keywords: INTERMUNE RESULTS/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nN01477288



More from Reuters

Pro Life Democrat Rep. Bart Stupak holds an Executive Order from U.S. President Barack Obama claiming no money from passage of the health care bill will be used for abortion while on Capitol Hill in Washington, March 21, 2010. At left is Rep. Kathleen Dahlkemper (D-Pa).  REUTERS/Larry Downing

Healthcare overhaul headed for passage

House Democrats neared passage of a healthcare bill that would create the biggest policy changes in decades and hand President Obama a landmark victory.  Full Article | Video 

A soldier guards hundreds of bags of wheat seed in the isolated district of Nad Ali's district centre in the west of Helmand province, October 17, 2009

Dirty money and Afghan war

As the war in Afghanistan enters its ninth year, the U.S. has finally realized the best way to stop the conflict is to cut the flow of drug money, columnist Bernd Debusmann writes.   Commentary 

    An H1N1 flu vaccine inoculation is given at the Geisinger Medical Center in Danville, Pennsylvania October 28, 2009. REUTERS/Brad Bower

    A new stab at conquering pain

    Millions of people worldwide suffer chronic pain that can last weeks, months or years but relief may be on the way.  Full Article